Cargando…

Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects

Myometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, i.e., those with a high risk of lymph node metastases (LNM)....

Descripción completa

Detalles Bibliográficos
Autores principales: Liro, Marcin, Śniadecki, Marcin, Wycinka, Ewa, Wojtylak, Szymon, Brzeziński, Michał, Jastrzębska, Joanna, Wydra, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689828/
https://www.ncbi.nlm.nih.gov/pubmed/36359447
http://dx.doi.org/10.3390/diagnostics12112604
_version_ 1784836633059655680
author Liro, Marcin
Śniadecki, Marcin
Wycinka, Ewa
Wojtylak, Szymon
Brzeziński, Michał
Jastrzębska, Joanna
Wydra, Dariusz
author_facet Liro, Marcin
Śniadecki, Marcin
Wycinka, Ewa
Wojtylak, Szymon
Brzeziński, Michał
Jastrzębska, Joanna
Wydra, Dariusz
author_sort Liro, Marcin
collection PubMed
description Myometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, i.e., those with a high risk of lymph node metastases (LNM). The study’s objective was to answer the question of which TVS markers, or their combination, reflecting the molecular changes in EC, can improve the prediction of LNM. Methods: The TVS examination was performed on 116 consecutive EC patients included in this prospective study. The results from the final histopathology were a reference standard. Univariate and multivariate logistic models of analyzed TVS biomarkers (tumor [T] size, T area [AREA], T volume [SPE-VOL], MI, T-free distance to serosa [TFD], endo-myometrial irregularity, [EMIR], cervical stromal involvement, CSI) were evaluated to assess the relative accuracy of the possible LNM predictors., Spline functions were applied to avoid a potential bias in assuming linear relations between LNM and continuous predictors. Calculations were made in R using libraries splines, glmulti, and pROC. Results: LNM was found in 20 out of the 116 (17%) patients. In univariate analysis, only uMI, EMIR, uCSI and uTFD were significant predictors of LNM. The accuracy was 0.707 (AUC 0.684, 95% CI 0.568–0.801) for uMI (p < 0.01), 0.672 (AUC 0.664, 95% CI 0.547–0.781) for EMIR (p < 0.01), 0.776 (AUC 0.647, 95% CI 0.529–0.765) for uCSI (p < 0.01), and 0.638 (AUC 0.683, 95% CI 0.563–0.803) for uTFD (p < 0.05). The cut-off value for uTFD was 5.2 mm. However, AREA and VOL revealed a significant relationship by nonlinear analysis as well. Among all possible multivariate models, the one comprising interactions of splines of uTFD with uMI and splines of SPE-VOL with uCSI showed the most usefulness. Accuracy was 0.802 (AUC 0.791, 95% CI 0.673–0.91) Conclusions: A combination of uTFD for patients with uMI > 50%, and SPE-VOL for patients with uCSI, allows for the most accurate prediction of LNM in EC, rather than uMI alone.
format Online
Article
Text
id pubmed-9689828
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96898282022-11-25 Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects Liro, Marcin Śniadecki, Marcin Wycinka, Ewa Wojtylak, Szymon Brzeziński, Michał Jastrzębska, Joanna Wydra, Dariusz Diagnostics (Basel) Article Myometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, i.e., those with a high risk of lymph node metastases (LNM). The study’s objective was to answer the question of which TVS markers, or their combination, reflecting the molecular changes in EC, can improve the prediction of LNM. Methods: The TVS examination was performed on 116 consecutive EC patients included in this prospective study. The results from the final histopathology were a reference standard. Univariate and multivariate logistic models of analyzed TVS biomarkers (tumor [T] size, T area [AREA], T volume [SPE-VOL], MI, T-free distance to serosa [TFD], endo-myometrial irregularity, [EMIR], cervical stromal involvement, CSI) were evaluated to assess the relative accuracy of the possible LNM predictors., Spline functions were applied to avoid a potential bias in assuming linear relations between LNM and continuous predictors. Calculations were made in R using libraries splines, glmulti, and pROC. Results: LNM was found in 20 out of the 116 (17%) patients. In univariate analysis, only uMI, EMIR, uCSI and uTFD were significant predictors of LNM. The accuracy was 0.707 (AUC 0.684, 95% CI 0.568–0.801) for uMI (p < 0.01), 0.672 (AUC 0.664, 95% CI 0.547–0.781) for EMIR (p < 0.01), 0.776 (AUC 0.647, 95% CI 0.529–0.765) for uCSI (p < 0.01), and 0.638 (AUC 0.683, 95% CI 0.563–0.803) for uTFD (p < 0.05). The cut-off value for uTFD was 5.2 mm. However, AREA and VOL revealed a significant relationship by nonlinear analysis as well. Among all possible multivariate models, the one comprising interactions of splines of uTFD with uMI and splines of SPE-VOL with uCSI showed the most usefulness. Accuracy was 0.802 (AUC 0.791, 95% CI 0.673–0.91) Conclusions: A combination of uTFD for patients with uMI > 50%, and SPE-VOL for patients with uCSI, allows for the most accurate prediction of LNM in EC, rather than uMI alone. MDPI 2022-10-27 /pmc/articles/PMC9689828/ /pubmed/36359447 http://dx.doi.org/10.3390/diagnostics12112604 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liro, Marcin
Śniadecki, Marcin
Wycinka, Ewa
Wojtylak, Szymon
Brzeziński, Michał
Jastrzębska, Joanna
Wydra, Dariusz
Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title_full Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title_fullStr Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title_full_unstemmed Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title_short Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
title_sort incorporation of tumor-free distance and other alternative ultrasound biomarkers into a myometrial invasion-based model better predicts lymph node metastasis in endometrial cancer: evidence and future prospects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689828/
https://www.ncbi.nlm.nih.gov/pubmed/36359447
http://dx.doi.org/10.3390/diagnostics12112604
work_keys_str_mv AT liromarcin incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT sniadeckimarcin incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT wycinkaewa incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT wojtylakszymon incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT brzezinskimichał incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT jastrzebskajoanna incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects
AT wydradariusz incorporationoftumorfreedistanceandotheralternativeultrasoundbiomarkersintoamyometrialinvasionbasedmodelbetterpredictslymphnodemetastasisinendometrialcancerevidenceandfutureprospects